Robert Bruce's LLY Position Overview
Robert Bruce (via Bruce & Co., Inc.) currently holds 2,000 shares of Eli Lilly and Company (LLY) worth $1.53 M, representing 0.47% of the portfolio. First purchased in 2024-Q4, this short-term holding has been held for 4 quarters.
Based on 13F filings, Robert Bruce has maintained this position in LLY for several quarters, showing initial confidence in the investment.
Analysis based on 13F filings available since 2013 Q2
Robert Bruce's Eli Lilly and Company (LLY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Eli Lilly and Company (LLY) Trades by Robert Bruce
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2024 | +2,000 | New Buy | 2,000 | $772.00 |
Robert Bruce's Eli Lilly and Company Investment FAQs
Robert Bruce first purchased Eli Lilly and Company (LLY) in Q4 2024, acquiring 2,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Robert Bruce has held Eli Lilly and Company (LLY) for 4 quarters since Q4 2024. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Robert Bruce's largest addition to Eli Lilly and Company (LLY) was in Q4 2024, adding 2,000 shares worth $1.54 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Robert Bruce's firm, Bruce & Co., Inc., owns 2,000 shares of Eli Lilly and Company (LLY), valued at approximately $1.53 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Eli Lilly and Company (LLY) represents approximately 0.47% of Robert Bruce's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Robert Bruce's peak holding in Eli Lilly and Company (LLY) was 2,000 shares, as reported at the end of Q4 2024. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.